We are live on ! Find out more
CG

Carlyle Group Portfolio holdings

AUM $10.6B
1-Year Est. Return 11.25%
This Fund
S&P 500
This Quarter Est. Return
-23.45%
1 Year Est. Return
+11.25%
3 Year Est. Return
-0.47%
5 Year Est. Return
-4.92%
10 Year Est. Return
+7.54%
AUM
$4.15B
AUM Growth
+$3.19B
Cap. Flow
-$362M
Cap. Flow %
-8.74%
Top 10 Hldgs %
99.16%
Holding
32
New
6
Increased
2
Reduced
5
Closed
5

Top Buys

Rank Stock Value
1
SARO
StandardAero Inc
SARO
+$193M
2
WRD
WeRide Inc
WRD
+$56.1M
3
PONY
Pony AI Inc
PONY
+$31.4M
4
XCUR icon
Exicure
XCUR
+$2.28M
5
REPX icon
Riley Exploration Permian
REPX
+$305K

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$377M
2
SLNO
Soleno Therapeutics
SLNO
+$140M
3
GTM
ZoomInfo Technologies
GTM
+$120M
4
SPWR icon
SunPower Inc
SPWR
+$5.92M
5
GETY icon
Getty Images
GETY
+$1.72M

Sector Composition

Rank Sector Weight
1 Industrials 93.51%
2 Healthcare 3.16%
3 Technology 2.09%
4 Real Estate 0.6%
5 Communication Services 0.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SARO
1
StandardAero Inc
SARO
$8.89B
$3.87B 93.2%
+6,675,862
New +$193M
SLNO
2
DELISTED
Soleno Therapeutics
SLNO
$61.8M 1.49%
1,375,646
-2,695,916
-66% -$140M
WRD
3
WeRide Inc
WRD
$1.97B
$48.5M 1.17%
+3,423,023
New +$56.1M
PONY
4
Pony AI Inc
PONY
$2.89B
$33.9M 0.82%
+2,362,447
New +$31.4M
PHAT icon
5
Phathom Pharmaceuticals
PHAT
$873M
$28.4M 0.68%
3,496,808
– –
JSPR icon
6
Jasper Therapeutics
JSPR
$24.8M
$22.7M 0.55%
1,066,189
– –
GETY icon
7
Getty Images
GETY
$216M
$18.8M 0.45%
8,684,599
-528,200
-6% -$1.72M
INVH icon
8
Invitation Homes
INVH
$17.9B
$15.3M 0.37%
477,500
– –
CUBE icon
9
CubeSmart
CUBE
$9.48B
$9.45M 0.23%
220,500
– –
SMHI icon
10
SEACOR Marine Holdings
SMHI
$214M
$8.89M 0.21%
1,355,761
+24,099
+2% +$179K
FWRD icon
11
Forward Air
FWRD
$435M
$4.1M 0.1%
107,214
– –
XCUR icon
12
Exicure
XCUR
$10.7M
$3.85M 0.09%
281,636
+225,308
+400% +$2.28M
HLVX
13
DELISTED
HilleVax
HLVX
$3.82M 0.09%
1,838,486
– –
QTTB icon
14
Q32 Bio
QTTB
$255M
$3.78M 0.09%
1,102,741
– –
SPWR icon
15
SunPower Inc
SPWR
$102M
$3.55M 0.09%
1,984,619
-2,916,721
-60% -$5.92M
EM
16
DELISTED
Smart Share Global Ltd
EM
$3.46M 0.08%
4,810,209
– –
DNUT icon
17
Krispy Kreme
DNUT
$569M
$3.38M 0.08%
340,748
– –
ACET icon
18
Adicet Bio
ACET
$75.9M
$2.84M 0.07%
184,295
– –
OKUR
19
OnKure Therapeutics
OKUR
$170M
$2.33M 0.06%
269,895
-1
-0% -$15
SPRB
20
Spruce Biosciences
SPRB
$120M
$1.22M 0.03%
38,620
– –
NABL icon
21
N-able
NABL
$899M
$875K 0.02%
93,732
– –
CART icon
22
Maplebear
CART
$10.8B
$340K 0.01%
8,219
-5,475
-40% -$237K
REPX icon
23
Riley Exploration Permian
REPX
$759M
$315K 0.01%
+9,880
New +$305K
HOOD icon
24
Robinhood
HOOD
$89.7B
$233K 0.01%
+6,242
New +$202K
SYRE icon
25
Spyre Therapeutics
SYRE
$8.7B
$224K 0.01%
9,620
– –
1
2

Similar funds

SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
BMSSC
B. Metzler seel. Sohn & Co Frankfurt, Germany $10.8B AUM 21.99% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
HTC
Haverford Trust Company Radnor, Pennsylvania $10.9B AUM 18.64% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return

Carlyle Group's Q4 2024 Portfolio in Review

As of Q4 2024, Carlyle Group held 32 positions worth $4.15B, up 335% from $954M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Carlyle Group withdrew a net $362M in Q4 2024, closing 5 positions and reducing 5 holdings. Its most notable exit was QuidelOrtho, an estimated $377M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 94% of assets, up from 1.8% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Carlyle Group opened a new position in StandardAero Inc worth $3.87B.

  • Carlyle Group's largest Q4 2024 buy was StandardAero Inc: 6,675,862 shares worth $3.87B.
  • Carlyle Group added most to Exicure in Q4 2024, an estimated $2.28M increase.
  • Carlyle Group's biggest Q4 2024 reduction was Soleno Therapeutics, cutting an estimated $140M.
  • Carlyle Group fully exited QuidelOrtho in Q4 2024, selling an estimated $377M.
  • Carlyle Group's ten largest holdings make up 99% of its $4.15B portfolio in Q4 2024.
  • Carlyle Group opened 6 new positions and closed 5 in Q4 2024.
  • Carlyle Group's portfolio value rose 335% quarter-over-quarter to $4.15B.

Based on Carlyle Group's 13F filing for Q4 2024, filed 13 Feb 2025.